AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
AVITA Medical (NASDAQ: RCEL) has announced its inaugural Acute Wound Care Showcase 2025, scheduled for May 13, 2025, at 11:00 a.m. Pacific Time via webcast. The event will feature presentations from CEO Jim Corbett and Dr. Katie Bush, Senior Vice President of Scientific and Medical Affairs.
The showcase will highlight AVITA Medical's comprehensive approach to acute wound care, featuring their product portfolio including RECELL®, Cohealyx™, and PermeaDerm®. Attendees will gain insights through physician testimonials and, for the first time, hear directly from patients whose lives have been transformed by these technologies.
The event will demonstrate the clinical and economic benefits of AVITA's technologies and conclude with a live Q&A session. Interested parties can register through the Events & Presentations section of AVITA Medical's Investor Relations website, with a replay available the following day.
AVITA Medical (NASDAQ: RCEL) ha annunciato il suo primo Acute Wound Care Showcase 2025, previsto per il 13 maggio 2025 alle 11:00 ora del Pacifico, trasmesso via webcast. L'evento includerà interventi del CEO Jim Corbett e della Dott.ssa Katie Bush, Vicepresidente Senior per gli Affari Scientifici e Medici.
Il showcase metterà in luce l'approccio completo di AVITA Medical alla cura delle ferite acute, presentando il loro portafoglio prodotti tra cui RECELL®, Cohealyx™ e PermeaDerm®. I partecipanti potranno ascoltare testimonianze di medici e, per la prima volta, sentire direttamente i pazienti le cui vite sono state trasformate da queste tecnologie.
L'evento illustrerà i benefici clinici ed economici delle tecnologie AVITA e si concluderà con una sessione di domande e risposte in diretta. Chi fosse interessato potrà registrarsi nella sezione Eventi e Presentazioni del sito Investor Relations di AVITA Medical, con la possibilità di rivedere la registrazione il giorno seguente.
AVITA Medical (NASDAQ: RCEL) ha anunciado su primer Acute Wound Care Showcase 2025, programado para el 13 de mayo de 2025 a las 11:00 a.m. hora del Pacífico, transmitido por webcast. El evento contará con presentaciones del CEO Jim Corbett y la Dra. Katie Bush, Vicepresidenta Senior de Asuntos Científicos y Médicos.
El showcase destacará el enfoque integral de AVITA Medical en el cuidado de heridas agudas, presentando su portafolio de productos que incluye RECELL®, Cohealyx™ y PermeaDerm®. Los asistentes obtendrán perspectivas a través de testimonios de médicos y, por primera vez, escucharán directamente a pacientes cuyas vidas han sido transformadas por estas tecnologías.
El evento demostrará los beneficios clínicos y económicos de las tecnologías de AVITA y concluirá con una sesión de preguntas y respuestas en vivo. Los interesados pueden registrarse en la sección de Eventos y Presentaciones del sitio web de Relaciones con Inversionistas de AVITA Medical, con una repetición disponible al día siguiente.
AVITA Medical (NASDAQ: RCEL)이 2025년 5월 13일 오전 11시(태평양 시간)에 웹캐스트로 진행되는 첫 번째 Acute Wound Care Showcase 2025를 발표했습니다. 이번 행사에는 CEO Jim Corbett와 과학 및 의료 담당 수석 부사장 Dr. Katie Bush가 발표자로 참여합니다.
이번 쇼케이스에서는 AVITA Medical의 급성 상처 치료에 대한 종합적인 접근법과 RECELL®, Cohealyx™, PermeaDerm® 등 제품 포트폴리오를 소개합니다. 참석자들은 의사들의 증언을 통해 인사이트를 얻고, 처음으로 이 기술들로 삶이 변화된 환자들의 직접적인 이야기도 들을 수 있습니다.
행사에서는 AVITA 기술의 임상적 및 경제적 이점을 시연하며, 라이브 질의응답 세션으로 마무리됩니다. 관심 있는 분들은 AVITA Medical 투자자 관계 웹사이트의 이벤트 및 발표 섹션에서 등록할 수 있으며, 다음 날 다시보기 영상도 제공됩니다.
AVITA Medical (NASDAQ : RCEL) a annoncé sa première Acute Wound Care Showcase 2025, prévue le 13 mai 2025 à 11h00, heure du Pacifique, diffusée en webcast. L'événement comprendra des présentations du PDG Jim Corbett et du Dr Katie Bush, vice-présidente principale des affaires scientifiques et médicales.
Le showcase mettra en avant l'approche globale d'AVITA Medical en matière de soins des plaies aiguës, présentant leur gamme de produits incluant RECELL®, Cohealyx™ et PermeaDerm®. Les participants bénéficieront de témoignages de médecins et, pour la première fois, écouteront directement des patients dont la vie a été transformée par ces technologies.
L'événement démontrera les avantages cliniques et économiques des technologies AVITA et se terminera par une session de questions-réponses en direct. Les personnes intéressées peuvent s'inscrire via la section Événements et Présentations du site Relations Investisseurs d'AVITA Medical, avec une rediffusion disponible le lendemain.
AVITA Medical (NASDAQ: RCEL) hat seine erste Acute Wound Care Showcase 2025 angekündigt, die am 13. Mai 2025 um 11:00 Uhr Pazifikzeit per Webcast stattfinden wird. Die Veranstaltung umfasst Präsentationen von CEO Jim Corbett und Dr. Katie Bush, Senior Vice President für Wissenschaftliche und Medizinische Angelegenheiten.
Die Showcase stellt AVITA Medicals umfassenden Ansatz zur Behandlung akuter Wunden vor und präsentiert das Produktportfolio mit RECELL®, Cohealyx™ und PermeaDerm®. Die Teilnehmer erhalten Einblicke durch Erfahrungsberichte von Ärzten und hören erstmals direkt von Patienten, deren Leben durch diese Technologien verändert wurden.
Die Veranstaltung zeigt die klinischen und wirtschaftlichen Vorteile der AVITA-Technologien auf und endet mit einer Live-Fragerunde. Interessierte können sich über den Bereich Events & Präsentationen auf der Investor Relations Webseite von AVITA Medical anmelden, eine Wiederholung steht am Folgetag zur Verfügung.
- None.
- None.
VALENCIA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will host its inaugural Acute Wound Care Showcase 2025 on Tuesday, May 13, 2025, via webcast at 11:00 a.m. Pacific Time.
The event will feature presentations from Jim Corbett, Chief Executive Officer, and Dr. Katie Bush, Senior Vice President of Scientific and Medical Affairs. The Acute Wound Care Showcase will provide an overview of AVITA Medical’s comprehensive approach to acute wound care. Attendees joining the webcast will gain insights into the company’s product portfolio, including RECELL®, Cohealyx™, and PermeaDerm®, as well as hear testimonials from physicians and patients.
“The Showcase is an opportunity to highlight how our product portfolio is reimagining acute wound care,” said Jim Corbett, Chief Executive Officer of AVITA Medical. “We will share compelling data and physician experiences that demonstrate the clinical and economic benefits of our technologies. For the first time, attendees will also hear directly from patients whose lives have been transformed by RECELL and our other products.”
The event will conclude with a live Q&A session. All interested parties may register and access the webcast via the Events & Presentations section of AVITA Medical’s Investor Relations site at ir.avitamedical.com. A replay will be available the following day.
About AVITA Medical, Inc.
AVITA Medical® is a leading therapeutic acute wound care company delivering transformative solutions. Our technologies are designed to optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of our platform is the RECELL® System, approved by the FDA for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin™ Cells, offering an innovative solution for improved clinical outcomes at the point-of-care. In the U.S., AVITA Medical also holds the exclusive rights to market, sell, and distribute both Cohealyx™, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm®, a biosynthetic wound matrix.
In international markets, the RECELL System is approved to promote skin healing in a wide range of applications including burns and full-thickness skin defects. The RECELL System, excluding RECELL GO®, is TGA-registered in Australia, has received CE mark approval in Europe, and has PMDA approval in Japan.
To learn more, visit www.avitamedical.com.
Authorized for release by the Chief Financial Officer of AVITA Medical, Inc.
Investor & Media Contact: Jessica Ekeberg Phone +1-661-904-9269 investor@avitamedical.com media@avitamedical.com
FAQ
When is AVITA Medical's Acute Wound Care Showcase 2025 and how can investors attend?
What products will be featured in RCEL's Acute Wound Care Showcase?
Who are the key speakers at AVITA Medical's 2025 Showcase?
Will there be patient testimonials at RCEL's 2025 Acute Wound Care Showcase?
How can investors access the replay of AVITA Medical's 2025 Showcase?
